<?xml version="1.0" encoding="UTF-8"?>
<document id="30412119">
	<sentence id="s1" text="Clinicopathologic features such as menarche age, body mass index, personal cancer history, grade, and histologic type were compared between the 2 groups.">
		<entity id="s1.e1" charOffset="54-58"
			type="GENE" text="mass" ontology_id="2200"/>
		<entity id="s1.e2" charOffset="75-81"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e3" charOffset="113-117"
			type="GENE" text="type" ontology_id="6445"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Univariate (Pearson Chi-squared test, Fisher exact test, T test, Wilcoxon rank sum test, logistic regression) statistics and stepwise multivariate logistic regression were used to identify factors associated with PFH in the analysis.Among young patients with EC, the PFH group had younger age-of-onset age of endometrial cancer (â‰¤40 years) (odds ratio [OR] = 2.21, 95% confidence interval [95% CI]: 1.01-4.82) than the NFH group.">
		<entity id="s2.e1" charOffset="74-78"
			type="GENE" text="rank" ontology_id="8792"/>
		<entity id="s2.e2" charOffset="321-327"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Colorectal, lung, endometrial, breast, and hepatocellular carcinoma accounted for 58.6% of all cancer types among 1st- and 2nd-degree relatives.">
		<entity id="s3.e1" charOffset="43-67"
			type="HP" text="hepatocellular carcinoma" ontology_id="HP_0001402"/>
		<entity id="s3.e2" charOffset="95-101"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e3" charOffset="102-106"
			type="GENE" text="type" ontology_id="6445"/>
		<pair id="s3.p1" e1="s3.e3"
		    e2="s3.e3" pgr="false"/>
		<pair id="s3.p2" e1="s3.e1"
		    e2="s3.e3" pgr="false"/>
	</sentence>
</document>
